CX3CR1-mediated Akt1 activation contributes to the paclitaxel-induced painful peripheral neuropathy in rats
D Li, H Chen, XH Luo, Y Sun, W Xia, YC Xiong - Neurochemical research, 2016 - Springer
Painful peripheral neuropathy is a serious dose-limiting side effect of paclitaxel therapy,
which unfortunately often happens during the optimal clinical management of chemotherapy …
which unfortunately often happens during the optimal clinical management of chemotherapy …
CX3CR1-Mediated Akt1 Activation Contributes to the Paclitaxel-Induced Painful Peripheral Neuropathy in Rats
D Li, H Chen, X Luo, Y Sun, W Xia… - Neurochemical …, 2016 - search.proquest.com
Painful peripheral neuropathy is a serious dose-limiting side effect of paclitaxel therapy,
which unfortunately often happens during the optimal clinical management of chemotherapy …
which unfortunately often happens during the optimal clinical management of chemotherapy …
CX3CR1-Mediated Akt1 Activation Contributes to the Paclitaxel-Induced Painful Peripheral Neuropathy in Rats
D Li, H Chen, XH Luo, Y Sun, W Xia, YC Xiong - Neurochemical Research, 2016 - infona.pl
Painful peripheral neuropathy is a serious dose-limiting side effect of paclitaxel therapy,
which unfortunately often happens during the optimal clinical management of chemotherapy …
which unfortunately often happens during the optimal clinical management of chemotherapy …
CX3CR1-Mediated Akt1 Activation Contributes to the Paclitaxel-Induced Painful Peripheral Neuropathy in Rats.
D Li, H Chen, XH Luo, Y Sun, W Xia… - Neurochemical …, 2016 - search.ebscohost.com
Painful peripheral neuropathy is a serious dose-limiting side effect of paclitaxel therapy,
which unfortunately often happens during the optimal clinical management of chemotherapy …
which unfortunately often happens during the optimal clinical management of chemotherapy …
CX3CR1-Mediated Akt1 Activation Contributes to the Paclitaxel-Induced Painful Peripheral Neuropathy in Rats.
D Li, H Chen, XH Luo, Y Sun, W Xia… - Neurochemical …, 2016 - europepmc.org
Painful peripheral neuropathy is a serious dose-limiting side effect of paclitaxel therapy,
which unfortunately often happens during the optimal clinical management of chemotherapy …
which unfortunately often happens during the optimal clinical management of chemotherapy …
CX3CR1-Mediated Akt1 Activation Contributes to the Paclitaxel-Induced Painful Peripheral Neuropathy in Rats
D Li, H Chen, XH Luo, Y Sun, W Xia… - Neurochemical …, 2016 - pubmed.ncbi.nlm.nih.gov
Painful peripheral neuropathy is a serious dose-limiting side effect of paclitaxel therapy,
which unfortunately often happens during the optimal clinical management of chemotherapy …
which unfortunately often happens during the optimal clinical management of chemotherapy …